Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Natural killer (NK) cells, total count

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 86357 refers to the measurement of total natural killer (NK) cell count through a blood test. Natural killer cells are a type of large granular lymphocyte that plays a crucial role in the immune system, particularly in the body's defense against tumors and virally infected cells. This test is essential for assessing the overall function of the immune system, as NK cells are integral to the body's ability to respond to infections and malignancies. The test is often performed alongside other immunological assessments, including tests for B-cells, T-cells, and specific subsets of T-cells, to provide a comprehensive evaluation of immune status. The procedure involves obtaining a blood sample through venipuncture, which is a standard method for collecting blood for laboratory analysis. The analysis of the blood sample is conducted using quantitative flow cytometry, a sophisticated technique that allows for the precise counting and characterization of different cell types within the blood. This detailed assessment is vital for diagnosing and monitoring various health conditions related to immune function.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The total count of natural killer (NK) cells is performed for various clinical indications, particularly when assessing immune function. The following conditions may warrant this test:

  • Immune System Disorders Assessment of patients with suspected immune deficiencies or disorders that may affect NK cell function.
  • Monitoring of Immunocompromised Patients Evaluation of patients undergoing treatments that may impact immune cell populations, such as chemotherapy or immunotherapy.
  • Evaluation of Viral Infections Investigation of patients with chronic viral infections where NK cell activity may be compromised.
  • Oncological Assessments Monitoring of patients with cancer, as NK cells play a role in tumor surveillance and response.

2. Procedure

The procedure for measuring total natural killer (NK) cell count involves several key steps:

  • Step 1: Patient Preparation The patient may be instructed to avoid certain medications or supplements prior to the blood draw, although specific instructions may vary based on clinical guidelines.
  • Step 2: Venipuncture A qualified healthcare professional performs venipuncture to obtain a blood sample. This involves inserting a needle into a vein, typically in the arm, to collect the necessary volume of blood for testing.
  • Step 3: Sample Handling The collected blood sample is properly labeled and transported to the laboratory for analysis. It is crucial to handle the sample according to laboratory protocols to ensure accurate results.
  • Step 4: Flow Cytometry Analysis In the laboratory, the blood sample undergoes quantitative flow cytometry. This technique utilizes lasers and fluorescent markers to identify and count the NK cells present in the sample, providing a total NK cell count.
  • Step 5: Result Interpretation The results are analyzed by a qualified laboratory professional, and the total NK cell count is reported. These results are then made available to the ordering physician for further evaluation and management.

3. Post-Procedure

After the procedure, patients may experience minor discomfort or bruising at the venipuncture site, which typically resolves quickly. There are no specific post-procedure care instructions required for this test, and patients can generally resume normal activities immediately. However, if any unusual symptoms occur, such as excessive bleeding or signs of infection at the puncture site, patients should contact their healthcare provider. The results of the NK cell count will be discussed with the patient during a follow-up appointment, where further diagnostic or therapeutic steps may be determined based on the findings.

Short Descr NK CELLS TOTAL COUNT
Medium Descr NATURAL KILLER CELLS TOTAL COUNT
Long Descr Natural killer (NK) cells, total count
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) No
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 235 - Other Laboratory
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
GA Waiver of liability statement issued as required by payer policy, individual case
GZ Item or service expected to be denied as not reasonable and necessary
91 Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient.
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
Q1 Routine clinical service provided in a clinical research study that is in an approved clinical research study
26 Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number.
77 Repeat procedure by another physician or other qualified health care professional: it may be necessary to indicate that a basic procedure or service was repeated by another physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 77 to the repeated procedure or service. note: this modifier should not be appended to an e/m service.
GW Service not related to the hospice patient's terminal condition
GY Item or service statutorily excluded, does not meet the definition of any medicare benefit or, for non-medicare insurers, is not a contract benefit
XU Unusual non-overlapping service, the use of a service that is distinct because it does not overlap usual components of the main service
Date
Action
Notes
2011-01-01 Changed Short description changed.
2006-01-01 Added First appearance in code book in 2006.
1992-12-31 Deleted Code deleted.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"